PULMONARY HYPERTENSION
Clinical trials for PULMONARY HYPERTENSION explained in plain language.
Never miss a new study
Get alerted when new PULMONARY HYPERTENSION trials appear
Sign up with your email to follow new studies for PULMONARY HYPERTENSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug study halted early after only 4 patients
Disease control TerminatedThis early-stage study tested an experimental drug called HS135 in obese people with both heart failure (with preserved pumping ability) and high blood pressure in the lungs. The goal was to check safety and how the drug works in the body. Only 4 patients took part before the stu…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE1 • Sponsor: 35Pharma Inc • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Lung drug study cut short: what we learned
Disease control TerminatedThis study looked at the safety of an inhaled medicine called treprostinil for people with both chronic obstructive pulmonary disease (COPD) and high blood pressure in the lungs (pulmonary hypertension). It included 41 adults who had already completed a previous study. The study …
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 04, 2026 16:21 UTC
-
Xenon MRI sheds light on hidden lung damage in hypertension patients
Knowledge-focused TerminatedThis study aimed to see if a special type of MRI, using xenon gas, could detect changes in the lungs of people with pulmonary hypertension (high blood pressure in the lungs). Researchers looked at how these MRI signals relate to disease severity and progression. The study involve…
Matched conditions: PULMONARY HYPERTENSION
Phase: PHASE2 • Sponsor: Bastiaan Driehuys • Aim: Knowledge-focused
Last updated May 17, 2026 00:32 UTC